Managers / Q4 2025 · view latest →
GSK plc
CIK 0001131399 · 79 NEW OXFORD STREET, LONDON, WC1A 1DG · 44 20 8047 5000
Reported Value
$799M
Q4 2025
Positions
15
Filings on Record
2
2019–present window
Filed
Feb 12, 2026
original filing
Summary
Gsk Plc reported $799M in U.S.-listed holdings across 15 positions for Q4 2025.
The portfolio is heavily concentrated: Wave Life Sciences alone accounts for 38.8% of reported value.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
Composition data arrives with ticker enrichment.
Quarter-over-Quarter Changes full breakdown →
Holdings — Q4 2025
Filing History
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.